Pharmacy and Pharmaceutical Conference

COVID-19 and Drug Repurposing

COVID-19 has expedited research on drug repurposing, a method that entails repurposing current pharmaceuticals. This strategy has proven invaluable throughout the pandemic since it makes use of well-known medications to promptly meet urgent requirements. Drugs that were initially designed for other illnesses, such as remdesivir and dexamethasone, have been proven to have therapeutic benefits for COVID-19 patients. Repurposing medications can lead to treatment more quickly than creating new ones from scratch. It also makes use of pre-existing safety data, which is important for responding to quickly changing health emergencies.

• Mechanisms of Drug Repurposing
• Clinical Trials and Evidence
• Drug Candidates for COVID-19